|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Acute myocardial infarction (AMI) is characterized by chest pain as well as cardiac troponin I (cTnI) and electrocardiography (ECG) changes.
|
31624755 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Early detection of cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), and myoglobin (Myo) is essential for the diagnosis of acute myocardial infarction (AMI) and heart failure (HF).
|
30985109 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
It was significantly available for microRNA-1 to early diagnose AMI with an optimal cutoff value of 2.215 and diagnostic accuracy could be improved when combined with cardiac troponin I.
|
30611212 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) are important diagnostic biomarkers for acute myocardial infarction (AMI).
|
31553332 |
2019 |
|
Acute myocardial infarction
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We found that plasma levels of miR-22-5p and miR-150-3p were significantly higher during the early stage of AMI and their expression levels peaked earlier than cTnI.
|
31179325 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rapid rule out of acute myocardial infarction in the observe zone using a combination of presentation N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin I.
|
31173734 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Measurement of cardiac troponin I in the blood is crucial for the early diagnosis of acute myocardial infarction.
|
31571481 |
2019 |
|
Acute myocardial infarction
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the commendable sensing performance of our proposed ELISA in the determination of the cTnI level in diluted human serum unambiguously illustrates great potential in the early diagnosis of acute myocardial infarction.
|
31124658 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
This work demonstrates the application of the LRSPP biosensors for the detection of human cardiac troponin I (cTnI) protein. cTnI is a biological marker for acute myocardial infarction (AMI), often referred to as a heart attack, which can be diagnosed by elevated levels of cTnI in patient blood.
|
30717341 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Because of their cardiac specificity, cardiac troponin I or T are the recommended biomarkers for diagnosing acute myocardial infarction.
|
30797799 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Due to its myocardial specificity, cTnI is widely used for the diagnosis of AMI diseases.
|
30471567 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Advancements in health care monitoring demand a rapid, accurate and reliable early diagnosis of "Heart Attack" (acute myocardial infarction) with an objective to develop a cost-effective, rapid and label-free point of care diagnostic test kit for the detection of cardiac troponin I (cTnI) on paper-based multi-frequency impedimetric transducers.
|
31844990 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cardiac troponin I (cTnI) was considered as the "gold standard" for acute myocardial infarction (AMI) diagnosis owing to its superior cardiac specificity for cardiac damage and showing little or no changes in patients with a skeletal muscle disease or trauma.
|
30666995 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Two-Hour Algorithm for Rapid Triage of Suspected Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay.
|
31570634 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, in order to rapidly detect AMI disease, the authors fabricated a label-free electrochemical biosensor composed of a multi-functional DNA structure on Au nanospike (AuNS) with a fabricated Au micro-gap electrode which was incorporated with a PCB chip in order to detect cardiac troponin I (cTnI).
|
30554012 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this work, we developed an electrochemical biosensor by using magnetic metal organic framework (MMOF) nanocatalysts and DNA nanotetrahedron (NTH) based dual-aptamer probes for nonenzymatic detection of cardiac troponin I (cTnI), a gold standard biomarker for the early diagnosis of AMI.
|
30954926 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, an enzyme linked DNA aptamer based assay was optimized for human cardiac troponin I (cTnI) detection which is a prominent biomarker for acute myocardial infarction (AMI), on an integrated microfluidic platform.
|
31317135 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
The AMI diagnostic efficacy of miR-1 and cTnI were similar (P > 0.05).
|
31611081 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, we construct a sandwich-type electrochemical immunosensor using TB-2HP5@Au-Pd/MnO<sub>2</sub> nanocomposites as the transducing materials for robust and ultrasensitive detection of cardiac troponin I (cTnI), a significant biomarker of acute myocardial infarction.
|
30745283 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
The interaction of cTnI with fGQDs for the early diagnosis of acute myocardial infarction was investigated using cyclic voltammetry (CV) and amperometry.
|
31758063 |
2019 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human cardiac troponin I (cTnI) has been regarded as a golden biomarker for AMI due to its excellent selectivity.
|
29725733 |
2018 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
A reliable lateral flow immunoassay (LFIA) based on a facile one-step synthesis of single microspheres in combining with immunochromatography technique was developed to establish a new point-of-care test (POCT) for the rapid and early detection of cardiac troponin I (cTnI), a kind of cardiac specific biomarker for acute myocardial infarction (AMI).
|
29735888 |
2018 |
|
Acute myocardial infarction
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A multivariate regression model showed as predictors for AMI the variables ECG data by admittance at the emergency room, previous AMI history, levels of both Mgb at the third hour, and cTnI at the sixth hour after admission.
|
29607545 |
2018 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
We aimed to evaluate the diagnostic performance of combinations of high-sensitivity (hs) cTnI and hs-cTnT for the early diagnosis of acute myocardial infarction.
|
29691270 |
2018 |
|
Acute myocardial infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
This biomedical sensor can be used in hospitals and homes alike, for early detection of cTnI which is a clinical marker for acute myocardial infarction.
|
29376635 |
2018 |